CIK: 0002081668
Total reported value
$172.8M
Reporting period: 2026-03-31 · Number of holdings: 4
Royalty Pharma Sub-Manager, LLC disclosed 4 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $172.8M and a quarterly turnover rate of 10.5%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "R"
Royalty Pharma Sub-Manager, LLC's disclosed holdings carry a Herfindahl concentration index of 0.279 — mathematically equivalent to about 4 equally-sized positions, close to its 4 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.39), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
Recent activity leans toward adding more aggressively to already-large existing positions than to newly initiated ones (a 26.8 percentage-point tilt) — a pattern consistent with a momentum-following approach.
Sector classification currently covers about 37% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Trim BHVN
0.0% -$8.3M
Add BCRX
0.0% $6.6M
Add CYTK
0.0% $2.3M
Add BCAX
+89.1% $823.4K
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | CYTK | Cytokinetics INC | Stock-Healthcare | 37.40% | +1.04% | — | |
| 2 | BCAX | Bicara Therapeutics INC | Stock-Other | 27.02% | +0.25% | +89.06% | |
| 3 | BCRX | Biocryst Pharmaceuticals INC | Stock-Other | 21.19% | +3.68% | — | |
| 4 | BHVN | Biohaven Ltd. | Stock-Other | 14.38% | -4.97% | — |
Performance for Q3 2026
+28.7%
Performance Last 4 Quarters
+31.9%
Based on 5 months of available history
Royalty Pharma Sub-Manager, LLC's most significant position changes for 2026-03-31: Add: Bicara Therapeutics INC (BCAX) — shares +89.06%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | BCRX | Biocryst Pharmaceuticals INC | +3.7% | — | Unchanged |
| 2 | CYTK | Cytokinetics INC | +1% | — | Unchanged |
| 3 | BCAX | Bicara Therapeutics INC | +0.3% | +89.06% | Add |
| 4 | BHVN | Biohaven Ltd. | -5% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-14 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-04-01 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001513779
Total reported value
$172.7M
60 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002010315
Total reported value
$172.9M
29 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001173889
Total reported value
$172.7M
12 stks
2026-03-31
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001012622
Total reported value
$167.9M
22 stks
2025-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Biohaven Ltd.
CIK 0001343781
Total reported value
$109.1M
22 stks
2022-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Cytokinetics INC
CIK 0001479355
Total reported value
$93.0M
21 stks
2016-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Biocryst Pharmaceuticals INC